Moderna
MRNA
#267
Rank
C$126.64 B
Marketcap
C$317.22
Share price
2.49%
Change (1 day)
808.79%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: C$126.64 Billion

As of November 2026 Moderna has a market cap of C$126.64 Billion. This makes Moderna the world's 267th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026C$126.64 B658.58%
2025C$16.69 B-24.66%
2024C$22.16 B-55.94%
2023C$50.29 B-46.29%
2022C$93.63 B-28.65%
2021C$131.23 B148.97%
2020C$52.71 B513.11%
2019C$8.59 B25.71%
2018C$6.83 B

End of Day market cap according to different sources

On Nov 1st, 2026 the market cap of Moderna was reported to be:

C$123.56 Billion
by Nasdaq info icon info icon
C$123.56 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$902.59 B 612.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$424.07 B 234.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$512.98 B 305.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
C$0.78 B-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
C$4.15 B-96.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
C$1.16 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$30.02 B-76.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C$11.81 B-90.67%๐Ÿ‡บ๐Ÿ‡ธ USA